12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Benitec, Genable deal

Benitec granted Genable exclusive, worldwide rights to DNA-directed RNA interference (ddRNAi) gene silencing technology. Genable said the deal will support its technology,...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >